Up to eleven percent of women of reproductive age could have endometriosis, an undiagnosed painful condition that makes the menstrual cycle harder and is linked to infertility. It’s caused by uterine tissue growth outside of the uterus and there is no cure. An injection therapy became...
You are here
Neurocrine Biosciences, Inc.
Company Information
Address
Neurocrine Biosciences, Inc.
12790 El Camino Real
San Diego, CA
92130
United States
Information
UEI: N/A
# of Employees: N/A
Ownership Information
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
N/A
Amount: $133,067.00N/A
SBIRPhase I2000Department of Health and Human Services National Institutes of Health -
N/A
Amount: $240,527.00N/A
SBIRPhase I2000Department of Health and Human Services National Institutes of Health -
N/A
Amount: $138,404.00N/A
SBIRPhase I2000Department of Health and Human Services National Institutes of Health -
CHR Binding Protein and Obesity
Amount: $1,197,014.00CRF, a 4l-amino acid peptide, plays a significant role in modulating inflammatory responses throughcoordinated actions in the nervous, endocrine and immune systems. CRF has indirect anti-inflammatorys ...
SBIRPhase II1998Department of Health and Human Services -
Novel CRF--Receptor
Amount: $750,000.00Corticotropin releasing factor (CRT), a 41 amino acid peptide, controls the anterior pituitary secradrenocorticotropin and other proopiomelanocortin products. CRT also coordinates the endocrine, behaa ...
SBIRPhase II1998Department of Health and Human Services -
METHOD TO IDENTIFY PHARMACOTHERAPIES FOR COCAINE ABUSE
Amount: $100,000.00N/A
SBIRPhase I1998Department of Health and Human Services -
IGFBP 3 LIGAND INHIBITORS FOR THE TREATMENT OF DIABETES
Amount: $100,000.00N/A
SBIRPhase I1997Department of Health and Human Services -
CRF BINDING PROTEIN AND OBESITY
Amount: $750,000.00N/A
SBIRPhase II1997Department of Health and Human Services -
CRF RECEPTOR ANTAGONISTS IN NEUROPROTECTION
Amount: $100,000.00N/A
SBIRPhase I1997Department of Health and Human Services -
Combinatorial Organic Synthesis of a CRF-R Antagonist
Amount: $749,963.00Corticotropin releasing factor (CRF), a 41 amino acid peptide, controls the anterior pituitarysecretion of adrenocorticotropin and other proopiomelanocortin products. CRF also coordinates theendocrine ...
SBIRPhase II1996Department of Health and Human Services
